NEXTCURE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.17 USD | -13.33% |
|
-23.53% | +2.63% |
Chart calendar NextCure, Inc.
2544d1.perilmIeL6zNd15A66O4ZOCdpd7TDsY43s6PhVdyH3g.4qu6wTNkeJ2XPhowhfLvCaTJ1LjiI6kLmofasWMYb0rKhbbZD0sdm4Inbg~2b10dd13e53dcedfb24768a771d996ee
Upcoming events on NextCure, Inc.
Past events on NextCure, Inc.
| 11/04/2024 10:15 pm | Needham Healthcare Conference |
| 08/04/2024 09:30 pm | American Association for Cancer Research Meeting - Abstract Number: 1898 |
| 21/03/2024 06:25 pm | Q4 2023 Earnings Release |
| 01/12/2023 12:00 am | Piper Sandler Healthcare Conference - Fireside Chat |
| 03/11/2023 01:35 am | Q3 2023 Earnings Release |
| 12/09/2023 02:30 am | H.C. Wainwright Global Investment Conference - Fireside Chat |
| 04/08/2023 01:35 am | Q2 2023 Earnings Release |
| 22/06/2023 | Annual General Meeting |
| 21/06/2023 05:00 pm | Federation of Clinical Immunology Societies Meeting - Abstract No: W189 |
| 16/05/2023 09:00 pm | JMP Securities Life Sciences Conference |
| 05/05/2023 01:35 am | Q1 2023 Earnings Release |
| 19/04/2023 07:45 pm | Needham Healthcare Conference |
| 03/03/2023 02:35 am | Q4 2022 Earnings Release |
| 16/02/2023 12:10 am | SVB Securities Global Biopharma Conference |
| 13/12/2022 | American Society of Hematology Meeting - Abstract 4088 |
| 09/12/2022 01:50 am | Bank of America Biotech SMID Cap Conference |
| 06/12/2022 08:30 pm | JMP Securities Hematology Oncology Summit |
| 30/11/2022 02:00 am | Piper Sandler Healthcare Conference |
| 12/11/2022 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 748 |
| 11/11/2022 06:00 am | Society for Immunotherapy of Cancer Meeting - Abstract Number: 739 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,35 5,89 7.84% | 22,4 22,4 -0.02% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -34,8 -36,8 5.45% | -37,8 -40,2 5.92% | -63,6 -72,9 12.83% | -71,8 -79,3 9.45% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -37,5 -36,8 -1.87% | -41,2 -42,4 2.73% | -70,8 -73,1 3.26% | -75,9 -77,4 1.97% | -67,6 -68,0 0.56% | -50,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,7 -32,1 -5.02% | -36,6 -37,3 1.77% | -69,4 -71,4 2.85% | -74,7 -76,8 2.68% | -62,7 -63,2 0.69% | -46,2 |
|
Net income Million USD | Released Forecast Spread | -33,7 -32,7 -3.18% | -36,6 -37,3 1.87% | -69,4 -71,5 2.97% | -74,7 -76,7 2.59% | -62,7 -63,4 1.02% | -46,9 |
|
EPS USD | Released Forecast Spread | -2,15 -2,03 -5.91% | -1,33 -1,34 0.66% | -2,51 -2,57 2.25% | -2,69 -2,65 -1.7% | -2,25 -2,28 1.1% | -1,67 |
| Announcement Date | 12/03/20 | 04/03/21 | 03/03/22 | 02/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -17,1 -19,5 12.24% | -20,8 -19,2 -7.97% | -18,1 -20,9 13.24% | -19,2 -19,7 2.28% | -17,8 -19,3 7.91% | -17,1 -17,7 3.61% | -19,2 -17,1 -12.19% | -15,6 -19,2 18.66% | -15,8 -16,2 2.42% | -13,8 | -12,5 | -11,8 | -12,1 | -11,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,9 -19,0 10.76% | -20,6 -18,6 -10.93% | -17,9 -20,8 13.76% | -18,9 -19,5 3.01% | -17,3 -19,2 9.81% | -16,1 -17,1 5.87% | -17,9 -16,3 -9.46% | -14,3 -18,2 21.27% | -14,5 -14,9 2.83% | -13,1 | -11,4 | -10,6 | -11,0 | -9,70 |
|
Net income Million USD | Released Forecast Spread | -16,9 -19,1 11.16% | -20,6 -18,6 -10.88% | -17,9 -20,6 13.11% | -18,9 -19,4 2.58% | -17,3 -19,2 9.76% | -16,1 -17,3 6.96% | -17,9 -16,5 -8.5% | -14,3 -18,4 22.17% | -14,5 -15,1 4.21% | -12,8 | -11,6 | -11,1 | -11,4 | -11,5 |
|
EPS USD | Released Forecast Spread | -0,61 -0,67 8.96% | -0,74 -0,67 -10.72% | -0,65 -0,74 12.36% | -0,68 -0,66 -3.03% | -0,62 -0,66 5.58% | -0,58 -0,62 6.45% | -0,64 -0,59 -8.47% | -0,51 -0,66 22.43% | -0,52 -0,54 4.15% | -0,46 | -0,41 | -0,40 | -0,40 | -0,41 |
| Announcement Date | 03/03/22 | 05/05/22 | 04/08/22 | 03/11/22 | 02/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 21/03/24 | - | - | - | - | - |
| Today 01:35 am | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 01/05/2024 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 04:30 pm | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 02/05/2024 01:35 am | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for NextCure, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NXTC Stock
- Calendar NextCure, Inc.
